We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
51.91%
This Fund
S&P 500
This Quarter
Est. Return
+4.73%
1 Year Est. Return
+51.91%
3 Year Est. Return
+141.83%
5 Year Est. Return
+190.65%
10 Year Est. Return
+978.24%
AUM
$4.49B
AUM Growth
+$553M
(+14%)
Cap. Flow
+$344M
Cap. Flow
% of AUM
7.67%
Top 10 Holdings %
Top 10 Hldgs %
31.45%
Holding
452
New
42
Increased
232
Reduced
111
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Select Dividend ETF
DVY
|
+$150M |
| 2 |
CVS Health
CVS
|
+$89M |
| 3 |
Procter & Gamble
PG
|
+$78.7M |
| 4 |
Microsoft
MSFT
|
+$72M |
| 5 |
VNET
VNET Group
VNET
|
+$46.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$97.2M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$68.7M |
| 3 |
Visa
V
|
+$51.3M |
| 4 |
Mastercard
MA
|
+$41.4M |
| 5 |
Comcast
CMCSA
|
+$39.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.58% |
| 2 | Financials | 15.25% |
| 3 | Healthcare | 13.12% |
| 4 | Communication Services | 12.45% |
| 5 | Technology | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WX
26
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $77.9M | 1.73% |
2,370,406
+14,028
| +0.6% | +$480K |
|
27
TripAdvisor
TRIP
$1.26B
| $70.5M | 1.57% |
649,022
-177,958
| -22% | -$16.4M |
|
|
VNET
28
VNET Group
VNET
$2.09B
| $67.4M | 1.5% |
2,249,263
+1,766,313
| +366% | +$46.4M |
|
29
Tesla
TSLA
$1.3T
| $67.3M | 1.5% |
4,204,500
-710,520
| -14% | -$9.91M |
|
30
Vipshop
VIPS
$7.53B
| $58.2M | 1.3% |
3,099,340
+1,442,040
| +87% | +$23.1M |
|
31
Apple
AAPL
$4.57T
| $53.3M | 1.19% |
2,293,648
+1,868,412
| +439% | +$39.8M |
|
32
Cognizant
CTSH
$26B
| $49.8M | 1.11% |
1,018,570
-327,268
| -24% | -$16M |
|
33
AbbVie
ABBV
$435B
| $42.6M | 0.95% |
754,263
+697,491
| +1,229% | +$36.6M |
|
34
Union Pacific
UNP
$174B
| $41.4M | 0.92% |
415,416
-41,362
| -9% | -$4.01M |
|
35
AB InBev
BUD
$165B
| $40.3M | 0.9% |
350,994
+159,934
| +84% | +$17.6M |
|
36
SPDR Gold Trust
GLD
$142B
| $36.5M | 0.81% |
284,740
+37,040
| +15% | +$4.6M |
|
37
Melco Resorts & Entertainment
MLCO
$2.14B
| $35.4M | 0.79% |
991,411
+320,710
| +48% | +$11.1M |
|
38
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $33.6M | 0.75% |
291,400
+61,400
| +27% | +$6.97M |
|
39
Amazon
AMZN
$2.96T
| $31.4M | 0.7% |
1,934,320
-1,153,440
| -37% | -$18.2M |
|
|
YHOO
40
DELISTED
Yahoo Inc
YHOO
| $30.9M | 0.69% |
880,390
-249,776
| -22% | -$8.72M |
|
41
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
| $30.1M | 0.67% |
+375,000
| New | +$30.1M |
|
42
Bristol-Myers Squibb
BMY
$132B
| $29.3M | 0.65% |
603,326
-9,200
| -2% | -$453K |
|
43
Biogen
BIIB
$30.7B
| $27.4M | 0.61% |
86,860
+83,231
| +2,293% | +$25.1M |
|
44
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $27.1M | 0.6% |
138,708
+110,420
| +390% | +$21M |
|
45
Texas Instruments
TXN
$261B
| $24.3M | 0.54% |
507,896
+434,984
| +597% | +$20.3M |
|
46
Capri Holdings
CPRI
$1.74B
| $24.2M | 0.54% |
+273,213
| New | +$25.1M |
|
47
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| $23M | 0.51% |
265,600
-347,400
| -57% | -$29.8M |
|
48
3M
MMM
$94.3B
| $21.8M | 0.49% |
182,340
+166,992
| +1,088% | +$19.6M |
|
|
JOYY
49
JOYY Inc
JOYY
$3.75B
| $21.5M | 0.48% |
285,150
-18,198
| -6% | -$1.19M |
|
50
Pfizer
PFE
$153B
| $20.2M | 0.45% |
716,498
+536,633
| +298% | +$15.3M |
|
Similar funds
Mirae Asset Global Investments's Q2 2014 Portfolio in Review
As of Q2 2014, Mirae Asset Global Investments held 452 positions worth $4.49B, up 14% from $3.94B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Mirae Asset Global Investments deployed $344M of net new capital in Q2 2014, opening 42 new positions and adding to 232 existing holdings. Its largest new stake was iShares Select Dividend ETF: 2,004,583 shares worth $154M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $97.2M trimmed.
- Mirae Asset Global Investments's largest Q2 2014 buy was iShares Select Dividend ETF: 2,004,583 shares worth $154M.
- Mirae Asset Global Investments added most to CVS Health in Q2 2014, an estimated $89M increase.
- Mirae Asset Global Investments's biggest Q2 2014 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $97.2M.
- Mirae Asset Global Investments fully exited State Street Financial Select Sector SPDR ETF in Q2 2014, selling an estimated $16.7M.
- Mirae Asset Global Investments's ten largest holdings make up 31% of its $4.49B portfolio in Q2 2014.
- Mirae Asset Global Investments opened 42 new positions and closed 37 in Q2 2014.
- Mirae Asset Global Investments's portfolio value rose 14% quarter-over-quarter to $4.49B.
Based on Mirae Asset Global Investments's 13F filing for Q2 2014, filed 13 Aug 2014.